1,721,150 research outputs found

    Hemadsorption in cardiac surgery: myth against reality

    No full text
    Cardiopulmonary bypass (CPB) surgery determines an unpredictable activation of a systemic inflammatory response induced by extrinsic and intrinsic factors.once activated by the extracorporeal circuit, this may lead to a dysregulation of inflammatory homeostasis, with increased levels of both pro-inflammatory — interleukin 1β (IL-1β) and tumor necrosis factor α (TNF-α) — and anti-inflammatory — IL-6, IL-8, IL-10 — plasma mediators. Both an excessive increase of pro-inflammatory plasma cytokines and an imbalance of pro- and anti-inflammatory mediators seem predictive for postoperative organ dysfunction and major complications, such as postoperative infection rates, mechanical ventilation need, prolonged postoperative course, thus for an unfavorable outcome. The elimination of both pro- and anti-inflammatory cytokine is supposed to reduce not only the inflammatory response but also the eventual immune imbalance; indeed, small molecules as cytokines may be eliminated by adsorption depending on their plasma concentration using the hemadsorption technique, with a possible improvement of cardiovascular function

    Are we ready for automated optimal cerebral perfusion pressure?

    Full text link
    Severe traumatic brain injury (TBI) may determine cerebral autoregulation derangements and cerebral blood flow (CBF) might become dependent on cerebral perfusion pressure (cPP). indeed, in healthy individuals CBF is adjusted by means of cerebral vessel vasodilatation and vasoconstriction, the so- called cerebral pressure autoregulation: the uninjured brain physiologically responds to variations in cerebral perfusion pressure (cPP) through constant modifications of CBF and vascular resistances

    Why are you so tired after surgery?

    No full text
    Pathophysiology, incidence and evolution of post-operative fatigu

    Is two (antibiotics) better than one?

    No full text
    The use of antibiotic therapy combining at least two drugs remains controversial in patients with severe sepsis and septic shock. Some studies have suggested an improvement in patients' outcome with combination therapy over monotherapy, especially in those patients with expected mortality exceeding 25%. Nevertheless, a recent large randomized multicentric clinical trial, comparing the effects of meropenem and moxifloxacin to meropenem alone on the occurrence of sepsis-related organ dysfunction, found no significant advantage for combination therapy. Also, mortality rates were similar at 28 days and at 90 days in both groups. Considering some opposite observations coming from other recent non-randomized studies, we aimed to discuss the raisons of these conflicting findings on antimicrobials combination in patients with severe sepsis and septic shock.Journal Articleinfo:eu-repo/semantics/publishe

    Editorial comment to intraoperative haemodynamic monitoring and management of adults having non-cardiac surgery: guidelines of the German society of Anaesthesiology and Intensive care medicine in collaboration with the German Association of the Scientific medical societies

    No full text
    In this issue, the German Society of Anaesthesiology and Intensive Care Medicine in collaboration with the German Association of the Scientific Medical Societies provide guidelines on intraoperative haemodynamic monitoring and management of adults having non-cardiac surgery. The document brings together a broad variety of data regarding perioperative haemodynamic management. Although a wide range of studies have been covered, no systematic literature search was conducted, and the methodology for appraising the evidence and formulating the recommendations is not described. Therefore, these guidelines should be viewed as a consensus of expert opinions, with questions identified by anaesthesiologists from three German university hospitals

    What have we learned from the surviving sepsis campaign?

    No full text
    The surviving Sepsis Campaign (SSC) was an initiative of the European Society of Intensive Care Medicine, the International Sepsis Forum and the Society of Critical Care Medicine. It was developed with the aim of improving the diagnosis and the treatment of sepsis. Some years after the Authors reflect on what the Surviving Sepsis Campaign has taught us. First of all the SSC has shown that it is possible to raise awareness among physicians and lay persons of an important disease process. The development of sespis bundles has helped promote discussion of the optimal approach to sepsis management and has introduce some degree of uniformity to the process of treating patients with severe sepsis. It has encouraged a more standardised approach to patient management at a global level, in particular in those hospitals in which patient care is substandard
    corecore